Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer Read more about Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer
A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC Read more about A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older Read more about Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older
Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer Read more about Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer
Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer Read more about Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer Read more about Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer
Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer Read more about Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer
Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly Read more about Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies Read more about A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer Read more about Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer